A sickle cell screen, also known as a sickle cell test or sickle cell screening, is a medical test used to determine whether an individual carries a gene mutation associated with sickle cell disease (SCD). Sickle cell disease is a genetic disorder that affects the shape of red blood cells, causing them to become rigid and assume a characteristic "sickle" shape. These misshapen red blood cells can lead to various health problems, including pain, anemia, and organ damage.
The sickle cell screen typically involves a blood test to detect the presence of abnormal hemoglobin, the protein responsible for carrying oxygen in red blood cells.
The two most common types of abnormal hemoglobin associated with sickle cell disease are:
-
Hemoglobin S (HbS): This is the abnormal hemoglobin found in individuals with sickle cell disease. People who inherit one copy of the HbS gene and one normal hemoglobin gene (HbA) are considered carriers or have sickle cell trait. They may not have symptoms of the disease but can pass the gene on to their offspring.
-
Hemoglobin C (HbC): Hemoglobin C is another abnormal hemoglobin variant that can be detected through screening. Individuals with one copy of the HbC gene and one normal hemoglobin gene (HbA) may have a condition called hemoglobin C trait.
The sickle cell screen is often performed as part of newborn screening programs, especially in regions where sickle cell disease is more common, such as parts of Africa, the Mediterranean, the Middle East, and certain areas in the Americas. Early detection through screening allows for timely intervention and management to prevent or mitigate the complications associated with sickle cell disease.
In addition to newborn screening, sickle cell screening may also be recommended for individuals who are planning to have children, as knowing their carrier status can help assess the risk of passing the disease to their offspring. It can also be offered to individuals from populations with a higher prevalence of sickle cell disease.
It's important to note that a sickle cell screen does not diagnose sickle cell disease itself but rather identifies carriers of the gene mutations associated with the condition. Further tests, such as hemoglobin electrophoresis or genetic testing, may be required to confirm the diagnosis of sickle cell disease or trait in individuals who screen positive.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.